[Neurodegenerative biomarkers of the response to diabetic macular edema treatment].
D V PetrachkovMaria BudzinskayaVladislav PavlovMadina DurzhinskayaAnait S KhalatyanPublished in: Vestnik oftalmologii (2020)
The course of intravitreal administration of the Aflibercept drug has been established to be an effective method of treating patients with clinically significant DME. Neurodegenerative biomarkers of the response to the anti-VEGF drug therapy have been determined: thickness of the peripapillary RNFL, GCL+ and GCL ++, as well as integrity of the ellipsoid zone.